RAD50

Across TCGA pan-cancer cohorts, RAD50 mass-spec protein differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of RAD50’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where RAD50 mass-spec protein is more highly expressed in tumor relative to normal tissue. In most cancer types RAD50 is over-expressed in tumor, although a few such as PDAC show the opposite, repressed pattern.

COAD, LSCC, and CCRCC are the cancer types where RAD50 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RAD50 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Male	III,IV	+0.551	<.001	11	view →
LSCC	Male	All	+0.315	<.001	9	view →
CCRCC	Male	III,IV	+0.301	<.001	9	view →
LUAD	Male	III,IV	+0.473	<.001	8	view →
OV	All	All	+0.584	.003	2	view →
PDAC	Female	III,IV	−0.374	.017	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

RAD50–COAD

Open the COAD breakdown →